NCT07252726 2026-02-09
Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
Ottawa Hospital Research Institute
Phase 4 Recruiting
Clinical Trials
8 trialsNCT00128297 2023-03-28
Pamidronate Administration in Breast Cancer Patients With Bone Metastases
Spanish Breast Cancer Research Group
Phase 4 Completed
NCT00128778 2023-03-06
Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients
Spanish Breast Cancer Research Group
Phase 4 Completed
NCT03220178 2022-01-06
PRECYCLE
Palleos Healthcare GmbH
Phase 4 Terminated
NCT02248571 2017-11-13
IMPROVE
iOMEDICO AG
Phase 4 Completed
NCT00434317 2017-02-23
Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases
Novartis
Phase 4 Completed
NCT01961544 2016-10-07
ESKIMO
Eisai Inc.
Phase 4 Completed
NCT00171847 2010-03-31
eLEcTRA
Novartis
Phase 4 Terminated